×

Behind the overnight slump in US biotech plays

10:24 PM ET Tue, 23 Dec 2014

Brewing price sensitivity in the sector, compounded with expensive valuations, led to the selloff in U.S. biotech stocks, says Peter Boockvar, Chief Market Analyst at The Lindsey Group.